CoChat

The Safety of Probiotics

Snydman, David R. · 2008 · Clinical Infectious Diseases

The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.

Abstract

Probiotics are generally defined as microorganisms that, when consumed, generally confer a health benefit on humans. There is considerable interest in probiotics for a variety of medical conditions, and millions of people around the world consume probiotics daily for perceived health benefits. Lactobacilli, bifidobacteria, and lactococci have generally been regarded as safe. There are 3 theoretical concerns regarding the safety of probiotics: (1) the occurrence of disease, such as bacteremia or endocarditis; (2) toxic or metabolic effects on the gastrointestinal tract; and (3) the transfer of antibiotic resistance in the gastrointestinal flora. In this review, the evidence for safety of the use of or the study of probiotics is examined. Although there are rare cases of bacteremia or fungemia related to the use of probiotics, epidemiologic evidence suggests no population increase in risk on the basis of usage data. There have been many controlled clinical trials on the use of probiotics that demonstrate safe use. The use of probiotics in clinical trials should be accompanied by the use of a data-safety monitoring board and by knowledge of the antimicrobial susceptibilities of the organism used.

Overview

Integrity signals

Registry

Crossref · 10.1086/523331

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 12

  1. Biller JA, 1995, J Pediatr Gastroenterol Nutr, 21, 224, 10.1097/00005176-199508000-00016 · doi:10.1097/00005176-199508000-00016 · Paper page
  2. 10.1097/00005176-200005000-00004 · doi:10.1097/00005176-200005000-00004 · Paper page
  3. Isolauri E, 1991, Pediatrics, 88, 90
  4. Majamaa H, 1995, J Pediatr Gastroenterol Nutr, 20, 333, 10.1097/00005176-199504000-00012 · doi:10.1097/00005176-199504000-00012 · Paper page
  5. 10.1097/00005176-199711000-00005 · doi:10.1097/00005176-199711000-00005 · Paper page
  6. McFarland LV, 1995, Am J Gastroenterol, 90, 439
  7. 10.1111/j.1574-695X.2001.tb01549.x · DOI · Paper page
  8. Yamazaki S, 1985, Immunology, 56, 43
  9. 10.1111/j.1572-0241.2002.05946.x · doi:10.1111/j.1572-0241.2002.05946.x · Paper page
  10. 10.1097/00005176-200003000-00014 · doi:10.1097/00005176-200003000-00014 · Paper page
  11. Gasson MJ, 1997, London: Blackie Academics & Professional, 1
  12. 10.1586/14787210.4.2.261 · DOI · Paper page

Cited by

See all 336

Metadata

Authors
Snydman, D. R.
Affiliations
Tufts University (US)
Corresponding author
Snydman, David R.
Venue
Clinical Infectious Diseases
Published
2008-02
Volume
46
Issue
s2
Pages
S104-S111
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2114923501
Cited by
336
References
116
Citations by year
2026: 9 · 2025: 14 · 2024: 22 · 2023: 19 · 2022: 18 · 2021: 18 · 2020: 12 · 2019: 19 · 2018: 14 · 2017: 17 · 2016: 21 · 2015: 22 · 2014: 22 · 2013: 22 · 2012: 24
FWCI
2.79
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • General Mills
  • California Dairy Research Foundation
  • National Institutes of Health (5r21at001892-02)
  • National Center for Complementary and Alternative Medicine
  • National Center for Complementary and Integrative Health (1R21 AT001892)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
Keywords
probiotics, probiotic safety, bacteremia, endocarditis, fungemia, antibiotic resistance transfer, gastrointestinal toxicity, lactobacilli, Bifidobacterium, lactococci, safety monitoring, antimicrobial susceptibility
MeSH terms
Animals, Bacteria, Clinical Trials as Topic, Consumer Product Safety, Drug Resistance, Microbial, Genetic Engineering, Humans, Lactobacillus, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.